These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 4826492

  • 1. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
    Bono VH.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
    [No Abstract] [Full Text] [Related]

  • 2. Biochemical aspects of drug combinations.
    Brockman RW.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract] [Full Text] [Related]

  • 3. An outline of cancer chemotherapy.
    Connors TA.
    Rev Roum Inframicrobiol; 1971 Mar; 8(3):135-51. PubMed ID: 5152643
    [No Abstract] [Full Text] [Related]

  • 4. Cell-kill kinetics of several S-phase-specific drugs.
    Bhuyan BK, Fraser TJ, Gray LG, Kuentzel SL, Neil GL.
    Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241
    [No Abstract] [Full Text] [Related]

  • 5. Action of camptothecin on mammalian cells in culture.
    Li LH, Fraser TJ, Olin EJ, Bhuyan BK.
    Cancer Res; 1972 Dec; 32(12):2643-50. PubMed ID: 4674679
    [No Abstract] [Full Text] [Related]

  • 6. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL, Homan ER.
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract] [Full Text] [Related]

  • 7. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK, Fraser TJ, Day KJ.
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
    Perchellet JP, Perchellet EM, Newell SW, Freeman JA, Ladesich JB, Jeong Y, Sato N, Buszek K.
    Anticancer Res; 1998 Dec; 18(1A):97-106. PubMed ID: 9568062
    [Abstract] [Full Text] [Related]

  • 9. Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
    Hall IH, Taylor K, Izydore RA, Daniels DL.
    Pharmazie; 1998 Nov; 53(11):794-9. PubMed ID: 9853360
    [No Abstract] [Full Text] [Related]

  • 10. [Screening methods--evaluation of cytostatics].
    Svec F.
    Cas Lek Cesk; 1972 Nov 03; 111(45):1062-3. PubMed ID: 5084857
    [No Abstract] [Full Text] [Related]

  • 11. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM, Sperfslage BJ, McIlvain CJ, Aligiannis N, Pouli N, Marakos P, Skaltsounis AL, Perchellet JP.
    Anticancer Res; 2001 Nov 03; 21(6A):3957-67. PubMed ID: 11911277
    [Abstract] [Full Text] [Related]

  • 12. Effects of hycanthone on rapidly proliferating cells.
    Sieber SM, Whang-Peng J, Johns DG, Adamson RH.
    Biochem Pharmacol; 1973 Jun 01; 22(11):1253-62. PubMed ID: 4353802
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the mechanism of action of DTIC (NSC-45388).
    Bono VH.
    Cancer Treat Rep; 1976 Feb 01; 60(2):141-8. PubMed ID: 944096
    [No Abstract] [Full Text] [Related]

  • 14. A modified screening system to select new cytostatic drugs.
    Kraemer HP, Sedlacek HH.
    Behring Inst Mitt; 1984 May 01; (74):301-28. PubMed ID: 6383326
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxicity of several marketed antibiotics on mammalian cells in culture.
    Li LH, Kuentzel SL, Shugars KD, Bhuyan BK.
    J Antibiot (Tokyo); 1977 Jun 01; 30(6):506-12. PubMed ID: 560364
    [No Abstract] [Full Text] [Related]

  • 16. Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
    Grieder A, Maurer R, Stähelin H.
    Cancer Res; 1977 Sep 01; 37(9):2998-3005. PubMed ID: 69488
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
    Shirakawa S, Frei E.
    Cancer Res; 1970 Aug 01; 30(8):2173-90. PubMed ID: 5459764
    [No Abstract] [Full Text] [Related]

  • 18. [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
    Belousova AK.
    Vopr Onkol; 1972 Aug 01; 18(8):88-96. PubMed ID: 4348595
    [No Abstract] [Full Text] [Related]

  • 19. Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia.
    Li LH, Kuentzel SL, Murch LL, Pschigoda LM, Krueger WC.
    Cancer Res; 1979 Dec 01; 39(12):4816-22. PubMed ID: 498110
    [No Abstract] [Full Text] [Related]

  • 20. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
    Csányi E, Halász M.
    Arzneimittelforschung; 1973 Jul 01; 23(7):961-7. PubMed ID: 4356189
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.